<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:33:03Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9542409" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9542409</identifier>
        <datestamp>2022-10-14</datestamp>
        <setSpec>blackwellopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="cncr34377" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Cancer</journal-id>
              <journal-id journal-id-type="iso-abbrev">Cancer</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)1097-0142</journal-id>
              <journal-id journal-id-type="publisher-id">CNCR</journal-id>
              <journal-title-group>
                <journal-title>Cancer</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0008-543X</issn>
              <issn pub-type="epub">1097-0142</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9542409</article-id>
              <article-id pub-id-type="pmcid">PMC9542409</article-id>
              <article-id pub-id-type="pmc-uid">9542409</article-id>
              <article-id pub-id-type="pmid">35797441</article-id>
              <article-id pub-id-type="pmid">35797441</article-id>
              <article-id pub-id-type="doi">10.1002/cncr.34377</article-id>
              <article-id pub-id-type="publisher-id">CNCR34377</article-id>
              <article-id pub-id-type="other">CNCR-21-3138.R2</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Articles</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Discipline</subject>
                    <subj-group subj-group-type="heading">
                      <subject>Survivorship</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Risk factors for breast cancer–related lymphedema in patients undergoing 3 years of prospective surveillance with intervention</article-title>
              </title-group>
              <contrib-group>
                <contrib id="cncr34377-cr-0001" contrib-type="author">
                  <name>
                    <surname>Koelmeyer</surname>
                    <given-names>Louise A.</given-names>
                  </name>
                  <degrees>PhD, OT</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2736-2330</contrib-id>
                  <xref rid="cncr34377-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0002" contrib-type="author">
                  <name>
                    <surname>Gaitatzis</surname>
                    <given-names>Katrina</given-names>
                  </name>
                  <degrees>Grad Dip(Psych)</degrees>
                  <xref rid="cncr34377-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0003" contrib-type="author">
                  <name>
                    <surname>Dietrich</surname>
                    <given-names>Mary S.</given-names>
                  </name>
                  <degrees>PhD, MS</degrees>
                  <xref rid="cncr34377-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0004" contrib-type="author">
                  <name>
                    <surname>Shah</surname>
                    <given-names>Chirag S.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9295-5554</contrib-id>
                  <xref rid="cncr34377-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0005" contrib-type="author">
                  <name>
                    <surname>Boyages</surname>
                    <given-names>John</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref rid="cncr34377-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cncr34377-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0006" contrib-type="author">
                  <name>
                    <surname>McLaughlin</surname>
                    <given-names>Sarah A.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="cncr34377-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0007" contrib-type="author">
                  <name>
                    <surname>Taback</surname>
                    <given-names>Bret</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="cncr34377-aff-0006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0008" contrib-type="author">
                  <name>
                    <surname>Stolldorf</surname>
                    <given-names>Deonni P.</given-names>
                  </name>
                  <degrees>PhD, RN</degrees>
                  <xref rid="cncr34377-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0009" contrib-type="author">
                  <name>
                    <surname>Elder</surname>
                    <given-names>Elisabeth</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <xref rid="cncr34377-aff-0007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <xref rid="cncr34377-aff-0008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                  <xref rid="cncr34377-aff-0009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0010" contrib-type="author">
                  <name>
                    <surname>Hughes</surname>
                    <given-names>T. Michael</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="cncr34377-aff-0010" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0011" contrib-type="author">
                  <name>
                    <surname>French</surname>
                    <given-names>James R.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="cncr34377-aff-0007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <xref rid="cncr34377-aff-0008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                  <xref rid="cncr34377-aff-0009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0012" contrib-type="author">
                  <name>
                    <surname>Ngui</surname>
                    <given-names>Nicholas</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="cncr34377-aff-0011" ref-type="aff">
                    <sup>11</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0013" contrib-type="author">
                  <name>
                    <surname>Hsu</surname>
                    <given-names>Jeremy M.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="cncr34377-aff-0007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                  <xref rid="cncr34377-aff-0009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                  <xref rid="cncr34377-aff-0012" ref-type="aff">
                    <sup>12</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0014" contrib-type="author">
                  <name>
                    <surname>Moore</surname>
                    <given-names>Andrew</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="cncr34377-aff-0013" ref-type="aff">
                    <sup>13</sup>
                  </xref>
                </contrib>
                <contrib id="cncr34377-cr-0015" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Ridner</surname>
                    <given-names>Sheila H.</given-names>
                  </name>
                  <degrees>PhD, RN</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3847-7405</contrib-id>
                  <xref rid="cncr34377-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <address>
                    <email>sheila.ridner@vanderbilt.edu</email>
                  </address>
                </contrib>
              </contrib-group>
              <aff id="cncr34377-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Australian Lymphoedema Education, Research, and Treatment (ALERT) Program, Faculty Medicine, Health &amp; Human Sciences</named-content>
                <institution>Macquarie University</institution>
                <city>Sydney</city>
                <named-content content-type="country-part">New South Wales</named-content>
                <country country="AU">Australia</country>
              </aff>
              <aff id="cncr34377-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Vanderbilt University School of Nursing</named-content>
                <institution>Vanderbilt University School of Medicine</institution>
                <city>Nashville</city>
                <named-content content-type="country-part">Tennessee</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cncr34377-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Department of Radiation Oncology, Taussig Cancer Institute</named-content>
                <institution>Cleveland Clinic</institution>
                <city>Cleveland</city>
                <named-content content-type="country-part">Ohio</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cncr34377-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <institution>Icon Cancer Centre</institution>
                <city>Sydney</city>
                <named-content content-type="country-part">New South Wales</named-content>
                <country country="AU">Australia</country>
              </aff>
              <aff id="cncr34377-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <institution>Mayo Clinic</institution>
                <city>Jacksonville</city>
                <named-content content-type="country-part">Florida</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="cncr34377-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <institution>Columbia University Vagelos College of Physicians and Surgeons</institution>
                <named-content content-type="country-part">New York</named-content>
                <city>New York</city>
                <country country="US">USA</country>
              </aff>
              <aff id="cncr34377-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <institution>Westmead Breast Cancer Institute</institution>
                <city>Westmead</city>
                <named-content content-type="country-part">New South Wales</named-content>
                <country country="AU">Australia</country>
              </aff>
              <aff id="cncr34377-aff-0008">
                <label>
                  <sup>8</sup>
                </label>
                <institution>The University of Sydney</institution>
                <city>Sydney</city>
                <named-content content-type="country-part">New South Wales</named-content>
                <country country="AU">Australia</country>
              </aff>
              <aff id="cncr34377-aff-0009">
                <label>
                  <sup>9</sup>
                </label>
                <institution>Lakeside Specialist Breast Clinic</institution>
                <city>Norwest</city>
                <named-content content-type="country-part">New South Wales</named-content>
                <country country="AU">Australia</country>
              </aff>
              <aff id="cncr34377-aff-0010">
                <label>
                  <sup>10</sup>
                </label>
                <named-content content-type="organisation-division">ANU Clinical School at Sydney Adventist Hospital</named-content>
                <institution>Australian National University</institution>
                <city>Canberra</city>
                <country country="AU">Australia</country>
              </aff>
              <aff id="cncr34377-aff-0011">
                <label>
                  <sup>11</sup>
                </label>
                <named-content content-type="organisation-division">Northern Surgical Oncology</named-content>
                <institution>Sydney Adventist Hospital</institution>
                <city>Wahroonga</city>
                <named-content content-type="country-part">New South Wales</named-content>
                <country country="AU">Australia</country>
              </aff>
              <aff id="cncr34377-aff-0012">
                <label>
                  <sup>12</sup>
                </label>
                <institution>Macquarie University</institution>
                <city>Macquarie</city>
                <named-content content-type="street">Park</named-content>
                <named-content content-type="country-part">New South Wales</named-content>
                <country country="AU">Australia</country>
              </aff>
              <aff id="cncr34377-aff-0013">
                <label>
                  <sup>13</sup>
                </label>
                <institution>Southeast Cancer Center</institution>
                <city>Cape Girardeau</city>
                <named-content content-type="country-part">Missouri</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Corresponding Author:</bold> Sheila H. Ridner, 524 Godchaux Hall, Vanderbilt School of Nursing, 461 21st Ave South, Nashville, TN 37240, USA (<email>sheila.ridner@vanderbilt.edu</email>).<break/>
</corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>07</day>
                <month>7</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <day>15</day>
                <month>9</month>
                <year>2022</year>
              </pub-date>
              <volume>128</volume>
              <issue seq="190">18</issue>
              <issue-id pub-id-type="doi">10.1002/cncr.v128.18</issue-id>
              <fpage>3408</fpage>
              <lpage>3415</lpage>
              <history>
                <date date-type="rev-recd">
                  <day>30</day>
                  <month>3</month>
                  <year>2022</year>
                </date>
                <date date-type="received">
                  <day>08</day>
                  <month>12</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>01</day>
                  <month>4</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <!--&#x000a9; 2022 American Cancer Society-->
                <copyright-statement content-type="article-copyright">© 2022 The Authors. <italic toggle="yes">Cancer</italic> published by Wiley Periodicals LLC on behalf of American Cancer Society.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:CNCR-128-3408.pdf"/>
              <abstract>
                <sec id="cncr34377-sec-0001">
                  <title>Background</title>
                  <p>To evaluate risk factors (treatment‐related, comorbidities, and lifestyle) for breast cancer–related lymphedema (BCRL) within the context of a Prospective Surveillance and Early Intervention (PSEI) model of care for subclinical BCRL.</p>
                </sec>
                <sec id="cncr34377-sec-0002">
                  <title>Methods</title>
                  <p>The parent randomized clinical trial assigned patients newly diagnosed with breast cancer to PSEI with either bioimpedance spectroscopy (BIS) or tape measurement (TM). Surgical, systemic and radiation treatments, comorbidities, and lifestyle factors were recorded. Detection of subclinical BCRL (change from baseline of either BIS L‐Dex ≥6.5 or tape volume ≥ 5% and &lt; 10%) triggered an intervention with compression therapy. Volume change from baseline ≥10% indicated progression to chronic lymphedema and need for complex decongestive physiotherapy. In this secondary analysis, multinomial logistic regressions including main and interaction effects of the study group and risk factors were used to test for factor associations with outcomes (no lymphedema, subclinical lymphedema, progression to chronic lymphedema after intervention, progression to chronic lymphedema without intervention). Post hoc tests of significant interaction effects were conducted using Bonferroni‐corrected alphas of .008; otherwise, an alpha of .05 was used for statistical significance.</p>
                </sec>
                <sec id="cncr34377-sec-0003">
                  <title>Results</title>
                  <p>The sample (<italic toggle="no">n</italic> = 918; TM = 457; BIS = 461) was female with a median age of 58.4 years. Factors associated with BCRL risk included axillary lymph node dissection (ALND) (<italic toggle="no">p</italic> &lt; .001), taxane‐based chemotherapy (<italic toggle="no">p</italic> &lt; .001), regional nodal irradiation (RNI) (<italic toggle="no">p</italic> ≤ .001), body mass index &gt;30 (<italic toggle="no">p</italic> = .002), and rurality (<italic toggle="no">p</italic> = .037). Mastectomy, age, hypertension, diabetes, seroma, smoking, and air travel were not associated with BCRL risk.</p>
                </sec>
                <sec id="cncr34377-sec-0004">
                  <title>Conclusions</title>
                  <p>Within the context of 3 years of PSEI for subclinical lymphedema, variables of ALND, taxane‐based chemotherapy, RNI, body mass index &gt;30, and rurality increased risk.</p>
                </sec>
              </abstract>
              <abstract abstract-type="short">
                <p>The Prospective Surveillance and Early Intervention Model promotes identification and treatment of subclinical lymphedema, facilitating prevention of chronic lymphedema and risk reduction. Axillary lymph node dissection, taxane‐based chemotherapy, regional nodal irradiation, body mass index &gt;30, and rurality are critical risk factors within the context of the Prospective Surveillance and Early Intervention Model for some patients.</p>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="cncr34377-kwd-0001">bioimpedance spectroscopy</kwd>
                <kwd id="cncr34377-kwd-0002">breast cancer</kwd>
                <kwd id="cncr34377-kwd-0003">intervention</kwd>
                <kwd id="cncr34377-kwd-0004">lymphedema</kwd>
                <kwd id="cncr34377-kwd-0005">prospective surveillance</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>ImpediMed</funding-source>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>medi</funding-source>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Center for Advancing Translational Sciences
</institution>
                      <institution-id institution-id-type="doi">10.13039/100006108</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>NIH/NCATS UL1 TR000445</award-id>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institutes of Health
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>TR000445</award-id>
                  <award-id>UL1</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="1"/>
                <table-count count="2"/>
                <page-count count="8"/>
                <word-count count="5400"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>September 15, 2022</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.0 mode:remove_FC converted:07.10.2022</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <fn-group id="cncr34377-ntgp-0001">
                <fn id="cncr34377-note-0001">
                  <p>See editorial on pages <ext-link xlink:href="https://doi.org/10.1002/cncr.34374" ext-link-type="uri">3284‐3286</ext-link>, this issue.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="cncr34377-body-0001">
            <sec id="cncr34377-sec-0005">
              <title>INTRODUCTION</title>
              <p>Breast cancer–related lymphedema (BCRL) affects an estimated 21% of breast cancer survivors (BCSs).<xref rid="cncr34377-bib-0001" ref-type="bibr"><sup>1</sup></xref>, <xref rid="cncr34377-bib-0002" ref-type="bibr"><sup>2</sup></xref> To reduce the risk of chronic BCRL (i.e., visible swelling in the arm), the Prospective Surveillance and Early Intervention (PSEI) model of care establishes a clinical pathway that commences with assessment of arm status at cancer diagnosis and proceeds with screening for subclinical BCRL (i.e., accumulation of extracellular fluid, no visible swelling) at regular intervals throughout cancer treatment and follow‐up.<xref rid="cncr34377-bib-0002" ref-type="bibr"><sup>2</sup></xref>, <xref rid="cncr34377-bib-0003" ref-type="bibr"><sup>3</sup></xref>, <xref rid="cncr34377-bib-0004" ref-type="bibr"><sup>4</sup></xref> The PSEI model integrates routine measurement, risk assessment, risk‐reduction education, and, ideally, compression therapy intervention for subclinical BCRL, all of which are key to reducing chronic BCRL risk.<xref rid="cncr34377-bib-0005" ref-type="bibr"><sup>5</sup></xref>, <xref rid="cncr34377-bib-0006" ref-type="bibr"><sup>6</sup></xref> Identification of change only in extracellular fluid using bioimpedance spectroscopy (BIS)–driven interventions for subclinical BCRL have been associated with less progression to chronic BCRL<xref rid="cncr34377-bib-0007" ref-type="bibr"><sup>7</sup></xref>, <xref rid="cncr34377-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="cncr34377-bib-0009" ref-type="bibr"><sup>9</sup></xref> than has identification of whole arm volume change (e.g., tape measurement [TM])<xref rid="cncr34377-bib-0007" ref-type="bibr"><sup>7</sup></xref>, <xref rid="cncr34377-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="cncr34377-bib-0009" ref-type="bibr"><sup>9</sup></xref> when following the PSEI model, which includes a short compression intervention.</p>
              <p>Despite this success, inconsistencies prevail in the literature regarding risk factors for progression to chronic BCRL. There is no known research regarding risk factors in patients undergoing compression for subclinical lymphedema as part of the PSEI model of care. This lack of evidence has made it difficult for clinicians to provide reliable risk assessment and risk‐reduction education to patients when implementing the PSEI model.</p>
              <p>Treatment‐related risk factors such as type of surgery (mastectomy vs. breast conservation surgery), axillary procedures (axillary lymph node dissection [ALND] vs. sentinel lymph node biopsy), radiotherapy (regional nodal irradiation [RNI]), and chemotherapy are well‐documented risk factors for chronic BCRL.<xref rid="cncr34377-bib-0010" ref-type="bibr"><sup>10</sup></xref>, <xref rid="cncr34377-bib-0011" ref-type="bibr"><sup>11</sup></xref>, <xref rid="cncr34377-bib-0012" ref-type="bibr"><sup>12</sup></xref>, <xref rid="cncr34377-bib-0013" ref-type="bibr"><sup>13</sup></xref>, <xref rid="cncr34377-bib-0014" ref-type="bibr"><sup>14</sup></xref>, <xref rid="cncr34377-bib-0015" ref-type="bibr"><sup>15</sup></xref>, <xref rid="cncr34377-bib-0016" ref-type="bibr"><sup>16</sup></xref>, <xref rid="cncr34377-bib-0017" ref-type="bibr"><sup>17</sup></xref> Studies have consistently demonstrated that the greater the extent of breast surgery, axillary procedures, and radiotherapy, the higher the chronic BCRL risk. With respect to systemic therapy, taxane‐based chemotherapy has been a suspected risk factor for almost a decade,<xref rid="cncr34377-bib-0013" ref-type="bibr"><sup>13</sup></xref> as has the combination of chemotherapy and ALND.<xref rid="cncr34377-bib-0017" ref-type="bibr"><sup>17</sup></xref> Seroma has also been associated with chronic BCRL.<xref rid="cncr34377-bib-0018" ref-type="bibr"><sup>18</sup></xref>, <xref rid="cncr34377-bib-0019" ref-type="bibr"><sup>19</sup></xref>, <xref rid="cncr34377-bib-0020" ref-type="bibr"><sup>20</sup></xref>, <xref rid="cncr34377-bib-0021" ref-type="bibr"><sup>21</sup></xref>, <xref rid="cncr34377-bib-0022" ref-type="bibr"><sup>22</sup></xref> Comorbidities such as age, body mass index (BMI), hypertension, and diabetes have been evaluated as risks factors for chronic BCRL with mixed results.<xref rid="cncr34377-bib-0023" ref-type="bibr"><sup>23</sup></xref>, <xref rid="cncr34377-bib-0024" ref-type="bibr"><sup>24</sup></xref>, <xref rid="cncr34377-bib-0025" ref-type="bibr"><sup>25</sup></xref>, <xref rid="cncr34377-bib-0026" ref-type="bibr"><sup>26</sup></xref>, <xref rid="cncr34377-bib-0027" ref-type="bibr"><sup>27</sup></xref>, <xref rid="cncr34377-bib-0028" ref-type="bibr"><sup>28</sup></xref>, <xref rid="cncr34377-bib-0029" ref-type="bibr"><sup>29</sup></xref>, <xref rid="cncr34377-bib-0030" ref-type="bibr"><sup>30</sup></xref> Finally, lifestyle behaviors such as smoking, air travel, and area of residence may also influence chronic BCRL risk.<xref rid="cncr34377-bib-0031" ref-type="bibr"><sup>31</sup></xref>, <xref rid="cncr34377-bib-0032" ref-type="bibr"><sup>32</sup></xref>, <xref rid="cncr34377-bib-0033" ref-type="bibr"><sup>33</sup></xref>, <xref rid="cncr34377-bib-0034" ref-type="bibr"><sup>34</sup></xref>, <xref rid="cncr34377-bib-0035" ref-type="bibr"><sup>35</sup></xref>, <xref rid="cncr34377-bib-0036" ref-type="bibr"><sup>36</sup></xref> Available literature regarding smoking is scant.<xref rid="cncr34377-bib-0030" ref-type="bibr"><sup>30</sup></xref>, <xref rid="cncr34377-bib-0031" ref-type="bibr"><sup>31</sup></xref>, <xref rid="cncr34377-bib-0032" ref-type="bibr"><sup>32</sup></xref> Despite limited prospective data available to evaluate the role of air travel,<xref rid="cncr34377-bib-0034" ref-type="bibr"><sup>34</sup></xref> up to 50% of BCSs avoid air travel because of the uncertain BCRL risk,<xref rid="cncr34377-bib-0034" ref-type="bibr"><sup>34</sup></xref> and a survey examining precipitating factors for chronic BCRL indicated 5.5% of patients reported air travel as the precipitating factor.<xref rid="cncr34377-bib-0035" ref-type="bibr"><sup>35</sup></xref> Additionally, rurality has been associated with increased postoperative symptoms, including lymphedema.<xref rid="cncr34377-bib-0036" ref-type="bibr"><sup>36</sup></xref>
</p>
              <p>Risk‐reduction guidelines range from simple strategies (e.g., good skin care) to potentially lifestyle altering (e.g., prophylactic compression garment use), but implementation does not guarantee reduced BCRL risk.<xref rid="cncr34377-bib-0037" ref-type="bibr"><sup>37</sup></xref> Given the importance of PSEI and initiation of subclinical BCRL interventions, research is needed on risk factors for subclinical and chronic lymphedema and the influence of measurement methods combined with compression intervention on factors leading to chronic BCRL. Thus, the purpose of this study was to conduct a secondary analysis to evaluate individual risk factors (treatment‐related, comorbidities, lifestyle) for BCRL and explore if PSEI plus a compression intervention for subclinical BCRL influences the factors leading to chronic BCRL.</p>
            </sec>
            <sec sec-type="methods" id="cncr34377-sec-0006">
              <title>METHODS</title>
              <sec id="cncr34377-sec-0007">
                <title>Study design and sample</title>
                <p>A prospective, multisite, international randomized, controlled trial enrolled women with newly diagnosed breast cancer before surgery, eligibility, and exclusion criteria previously published.<xref rid="cncr34377-bib-0007" ref-type="bibr"><sup>7</sup></xref>, <xref rid="cncr34377-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="cncr34377-bib-0009" ref-type="bibr"><sup>9</sup></xref> Study approval from all local research review boards, protocol posting on <ext-link xlink:href="http://www.clinicaltrials.gov" ext-link-type="uri">www.ClinicalTrials.gov</ext-link>, and informed consent were all obtained before enrollment in the study.</p>
              </sec>
              <sec id="cncr34377-sec-0008">
                <title>Randomization and assessments</title>
                <p>Baseline physical measurements and self‐report data were collected presurgery. Patients were randomized postoperatively to surveillance with either BIS or TM, with procedures previously documented.<xref rid="cncr34377-bib-0007" ref-type="bibr"><sup>7</sup></xref>, <xref rid="cncr34377-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="cncr34377-bib-0009" ref-type="bibr"><sup>9</sup></xref>, <xref rid="cncr34377-bib-0038" ref-type="bibr"><sup>38</sup></xref>, <xref rid="cncr34377-bib-0039" ref-type="bibr"><sup>39</sup></xref> Both assessment methods have been previously validated by the principal investigator of the parent study along with other published validation studies.<xref rid="cncr34377-bib-0040" ref-type="bibr"><sup>40</sup></xref>, <xref rid="cncr34377-bib-0041" ref-type="bibr"><sup>41</sup></xref>, <xref rid="cncr34377-bib-0042" ref-type="bibr"><sup>42</sup></xref>, <xref rid="cncr34377-bib-0043" ref-type="bibr"><sup>43</sup></xref>, <xref rid="cncr34377-bib-0044" ref-type="bibr"><sup>44</sup></xref> Intensive training was provided to all research staff at each site by the study principal investigator, as well as annual fidelity checks, before enrolling participants. Training was also conducted at regular intervals throughout the study period at each site to reduce variation in measurements and increase interrater reliability between research staff. Patients were measured with both BIS and TM at baseline, any time subclinical lymphedema was detected, and at the end of study participation regardless of reason. Progression to chronic lymphedema was determined solely by TM for both groups.</p>
                <p>For purposes of this study, the “no lymphedema” outcome group did not develop subclinical lymphedema, the “subclinical lymphedema” group developed subclinical lymphedema and received compression therapy intervention for 4 weeks and did not progress to chronic lymphedema after intervention, the “progression to chronic lymphedema postintervention” group developed chronic lymphedema following compression therapy intervention, and the “progression to chronic lymphedema without intervention” group developed chronic lymphedema before the opportunity of receiving compression therapy intervention. Data collection and medical record review were conducted individually at each site and directly entered into the REDCap research database/record by trained site staff.</p>
                <sec id="cncr34377-sec-0009">
                  <title>Treatment data and comorbidities</title>
                  <p>Breast cancer medical history and treatment (type/extent of nodal procedures, breast surgery, chemotherapy, and radiation) were collected at baseline and updated at each follow‐up. RNI was defined as radiation to chest wall or breast and any of the following: supraclavicular fossa, infraclavicular fossa, internal mammary chain, axilla level 3, or standard fractionation whole‐breast irradiation with high tangential fields. Medical records were accessed to determine postoperative seroma development. In the rare instance when medical history was not accessible, self‐reported presence of seroma was recorded. Weight and height were collected at baseline. Each measurement was taken twice, and the average was used to calculate BMI. Medical history and current comorbidities (hypertension and diabetes) were collected at baseline via self‐report and medical record review.</p>
                </sec>
                <sec id="cncr34377-sec-0010">
                  <title>Demographics and lifestyle</title>
                  <p>Self‐reported race, marital status, education level, employment, area of residence, age, and smoking history were collected at baseline. Air travel history was collected at each follow‐up through self‐report surveys. In addition to total number of flights taken with and without compression, for those patients who met the criteria for subclinical lymphedema, flights before and after intervention were also analyzed.</p>
                </sec>
              </sec>
              <sec id="cncr34377-sec-0011">
                <title>Statistical methods</title>
                <p>Descriptive statistical summaries of demographic and treatment characteristics were generated for the entire randomized sample and for each study arm. Those distributions were compared using likelihood ratio χ<sup>2</sup> statistics (nominal, ordinal categories) or Mann–Whitney tests (continuous). Each of the proposed risk factors were summarized by outcome group (no lymphedema, subclinical lymphedema, progression to chronic lymphedema after intervention, progression to chronic lymphedema without intervention) for the entire randomized sample. Multinomial logistic regressions were used to test the association of each factor with the outcome. An interaction term of study arm and factor was included in those regression models to test whether the association differed between the two arms. Pairwise post hoc tests among the four outcome groups were conducted of statistically significant factor effects using a Bonferroni‐corrected alpha of.008; otherwise, an alpha of.05 was used for determining statistical significance.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="cncr34377-sec-0012">
              <title>RESULTS</title>
              <sec id="cncr34377-sec-0013">
                <title>Sample</title>
                <p>Overall, 963 women were randomized to either TM (481) or BIS (482) prospective surveillance (Fig. <xref rid="cncr34377-fig-0001" ref-type="fig">1</xref>).<xref rid="cncr34377-bib-0007" ref-type="bibr"><sup>7</sup></xref> Of those, 45 had no postrandomization assessments; thus, a sample of 918 (457 TM, 461 BIS) patients was included in the outcome analyses. Almost one‐half of all the patients (42.4%) had some type of chemotherapy and, if they did, 88.4% had taxane‐based chemotherapy. Slightly more than 80% had some type of radiation therapy and, of those, 27.3% had RNI. Other than a slightly higher percentage of the patients in the BIS group reporting seroma (24.7% vs. 19.3%, <italic toggle="yes">p</italic> = .045), no statistically significant differences between the two study groups were observed in any of the key risk factors. Patients were a median 58.4 years of age, predominantly non‐Hispanic (96.3%), well‐educated (median, 16 years), and 78.2% identified as White race. Approximately one‐half (53.3%) dwelled in suburban areas, with the remaining split equally between urban and rural.</p>
                <fig position="float" fig-type="FIGURE" id="cncr34377-fig-0001">
                  <label>FIGURE 1</label>
                  <caption>
                    <p>CONSORT flow diagram. BIS indicates bioimpedance spectroscopy. <sup>a</sup>All patients randomized to tape measurement after postoperative reassessment. <sup>b</sup>All patients randomized to BIS after postoperative reassessment. <sup>c</sup>Patients who had incomplete or missing assessments were removed from analysis.</p>
                  </caption>
                  <graphic xlink:href="CNCR-128-3408-g001" position="anchor" id="jats-graphic-1"/>
                </fig>
                <p>Patients were assessed over a median of 32.8 months (interquartile range [IQR] = 21, 35) postoperatively. Within the sample outcome groups, 670 showed no indication of BCRL (no lymphedema, 73.0%), 179 (subclinical lymphedema, 19.5%), 30 (progressed to chronic lymphedema after intervention, 3.2%), and 39 (progressed to chronic lymphedema without intervention, 4.2%). Months on study were significantly different among the outcome groups because those who progressed with or without intervention were in the study for fewer months than those in the other two groups (median = 16.0 and 8.2, respectively, vs. 33.1 [no lymphedema] and 33.0 [subclinical lymphedema]).</p>
              </sec>
              <sec id="cncr34377-sec-0014">
                <title>Risk factor associations with outcome</title>
                <p>Summaries of the proposed risk factors by outcome group are shown in Table <xref rid="cncr34377-tbl-0001" ref-type="table">1</xref>.</p>
                <table-wrap position="float" id="cncr34377-tbl-0001" content-type="TABLE">
                  <label>TABLE 1</label>
                  <caption>
                    <p>Medical history and treatment factors by outcome group (<italic toggle="no">N</italic> = 918)</p>
                  </caption>
                  <table frame="hsides" rules="groups">
                    <col align="left" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <thead>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" rowspan="1" colspan="1"/>
                        <th align="left" rowspan="1" colspan="1">
                          <p>No lymphedema</p>
                          <p>(<italic toggle="yes">N</italic> = 670)</p>
                        </th>
                        <th align="left" rowspan="1" colspan="1">
                          <p>Subclinical lymphedema</p>
                          <p>(<italic toggle="yes">N</italic> = 179)</p>
                        </th>
                        <th align="left" rowspan="1" colspan="1">Chronic lymphedema after intervention (<italic toggle="yes">N</italic> = 30)</th>
                        <th align="left" style="border-bottom:solid 1px #000000" rowspan="1" colspan="1">Chronic lymphedema without intervention (<italic toggle="yes">N</italic> = 39)</th>
                        <th align="left" style="border-bottom:solid 1px #000000" rowspan="1" colspan="1">
                          <italic toggle="yes">p</italic>
                        </th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td colspan="6" style="background-color:#D9D9D9" align="left" rowspan="1">Factor</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td colspan="3" align="center" rowspan="1">Median [IQR] (Min, Max)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Age</td>
                        <td align="center" rowspan="1" colspan="1">
                          <p>58.4 [50, 66]</p>
                          <p>(28, 93)</p>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <p>58.8 [51, 67]</p>
                          <p>(34, 79)</p>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <p>60.7 [49, 70]</p>
                          <p>(41, 79)</p>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <p>56.3 [47, 68]</p>
                          <p>(43, 79)</p>
                        </td>
                        <td align="center" rowspan="1" colspan="1">.708</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Missing</td>
                        <td align="center" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">BMI</td>
                        <td align="center" rowspan="1" colspan="1">
                          <p>27.7 [24, 32]<sup>a</sup>
</p>
                          <p>(17, 61)</p>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <p>28.2 [24, 35]</p>
                          <p>(16, 58)</p>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <p>29.6 [26, 35]</p>
                          <p>(21, 47)</p>
                        </td>
                        <td align="center" rowspan="1" colspan="1">
                          <p>30.4 [26, 40]<sup>b</sup>
</p>
                          <p>(24, 49)</p>
                        </td>
                        <td align="center" rowspan="1" colspan="1">.002</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">No. (%)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">History/current hypertension</td>
                        <td align="center" rowspan="1" colspan="1">209 (31.2)</td>
                        <td align="center" rowspan="1" colspan="1">65 (36.5)</td>
                        <td align="center" rowspan="1" colspan="1">12 (40.0)</td>
                        <td align="center" rowspan="1" colspan="1">16 (41.0)</td>
                        <td align="center" rowspan="1" colspan="1">.300</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Missing</td>
                        <td align="center" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">History/current diabetes</td>
                        <td align="center" rowspan="1" colspan="1">55 (8.2)</td>
                        <td align="center" rowspan="1" colspan="1">17 (9.6)</td>
                        <td align="center" rowspan="1" colspan="1">3 (10.0)</td>
                        <td align="center" rowspan="1" colspan="1">5 (12.8)</td>
                        <td align="center" rowspan="1" colspan="1">.766</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Missing</td>
                        <td align="center" rowspan="1" colspan="1">3</td>
                        <td align="center" rowspan="1" colspan="1">2</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Area of residence</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">.037</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">City/urban</td>
                        <td align="center" rowspan="1" colspan="1">159 (23.9)</td>
                        <td align="center" rowspan="1" colspan="1">50 (28.1)</td>
                        <td align="center" rowspan="1" colspan="1">5 (16.7)</td>
                        <td align="center" rowspan="1" colspan="1">5 (12.8)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Suburban</td>
                        <td align="center" rowspan="1" colspan="1">359 (53.9)</td>
                        <td align="center" rowspan="1" colspan="1">89 (50.0)</td>
                        <td align="center" rowspan="1" colspan="1">17 (56.7)</td>
                        <td align="center" rowspan="1" colspan="1">16 (41.0)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Rural</td>
                        <td align="center" rowspan="1" colspan="1">148 (22.2)<sup>a</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">39 (21.9)<sup>a</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">8 (26.7)</td>
                        <td align="center" rowspan="1" colspan="1">18 (46.2)<sup>b</sup>
</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Missing</td>
                        <td align="center" rowspan="1" colspan="1">4</td>
                        <td align="center" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Seroma</td>
                        <td align="center" rowspan="1" colspan="1">142 (21.2)</td>
                        <td align="center" rowspan="1" colspan="1">44 (24.6)</td>
                        <td align="center" rowspan="1" colspan="1">8 (26.7)</td>
                        <td align="center" rowspan="1" colspan="1">8 (20.5)</td>
                        <td align="center" rowspan="1" colspan="1">.718</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">History of smoking</td>
                        <td align="center" rowspan="1" colspan="1">222 (33.2)</td>
                        <td align="center" rowspan="1" colspan="1">59 (33.0)</td>
                        <td align="center" rowspan="1" colspan="1">13 (43.3)</td>
                        <td align="center" rowspan="1" colspan="1">18 (46.2)</td>
                        <td align="center" rowspan="1" colspan="1">.277</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Missing</td>
                        <td align="center" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Mastectomy</td>
                        <td align="center" rowspan="1" colspan="1">135 (20.2)</td>
                        <td align="center" rowspan="1" colspan="1">48 (27.0)</td>
                        <td align="center" rowspan="1" colspan="1">11 (36.7)</td>
                        <td align="center" rowspan="1" colspan="1">9 (23.1)</td>
                        <td align="center" rowspan="1" colspan="1">.069</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Missing</td>
                        <td align="center" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">ALND</td>
                        <td align="center" rowspan="1" colspan="1">89 (13.3)<sup>a</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">45 (25.1)<sup>b</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">17 (56.7)<sup>c</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">23 (59.0)<sup>c</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">&lt;.001</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Missing</td>
                        <td align="center" rowspan="1" colspan="1">2</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Chemotherapy</td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">&lt;.001</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">None</td>
                        <td align="center" rowspan="1" colspan="1">408 (61.0)<sup>a</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">98 (54.7)<sup>a,b</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">8 (26.7)<sup>c</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">14 (35.9)<sup>b,c</sup>
</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Not taxane</td>
                        <td align="center" rowspan="1" colspan="1">36 (5.4)</td>
                        <td align="center" rowspan="1" colspan="1">6 (3.4)</td>
                        <td align="center" rowspan="1" colspan="1">1 (3.3)</td>
                        <td align="center" rowspan="1" colspan="1">2 (5.1)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Taxane</td>
                        <td align="center" rowspan="1" colspan="1">225 (33.6)<sup>a</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">75 (41.9)<sup>a,b</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">21 (70.0)<sup>c</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">23 (59.0)<sup>b,c</sup>
</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Missing</td>
                        <td align="center" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1">0</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">RT (any)</td>
                        <td align="center" rowspan="1" colspan="1">560 (83.6)</td>
                        <td align="center" rowspan="1" colspan="1">152 (84.9)</td>
                        <td align="center" rowspan="1" colspan="1">23 (76.7)</td>
                        <td align="center" rowspan="1" colspan="1">26 (66.7)</td>
                        <td align="center" rowspan="1" colspan="1">.057</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">If RT, RNI<xref rid="cncr34377-note-0004" ref-type="table-fn">d</xref>
</td>
                        <td align="center" rowspan="1" colspan="1">128 (23.6) <sup>a</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">51 (34.2)</td>
                        <td align="center" rowspan="1" colspan="1">11 (50.0) <sup>b</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">11 (47.8) <sup>b</sup>
</td>
                        <td align="center" rowspan="1" colspan="1">&lt;.001</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" rowspan="1" colspan="1">Missing</td>
                        <td align="center" rowspan="1" colspan="1">17</td>
                        <td align="center" rowspan="1" colspan="1">3</td>
                        <td align="center" rowspan="1" colspan="1">1</td>
                        <td align="center" rowspan="1" colspan="1">3</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot id="cncr34377-ntgp-0002">
                    <fn id="cncr34377-note-0002">
                      <p>Abbreviations: ALND, axillary lymph node dissection; BMI, body mass index; IQR, interquartile range; RNI, regional node irradiation; RT, radiotherapy.</p>
                    </fn>
                    <fn id="cncr34377-note-0003">
                      <label>
                        <sup>a,b,c</sup>
                      </label>
                      <p>Statistically significant differences between the outcome groups (Bonferroni‐corrected, <italic toggle="yes">p</italic> &lt; .008).</p>
                    </fn>
                    <fn id="cncr34377-note-0004">
                      <label>
                        <sup>d</sup>
                      </label>
                      <p>Of cases for whom RNI could be determined. No lymphedema: <italic toggle="yes">N</italic> = 543, subclinical lymphedema only: <italic toggle="yes">N</italic> = 149, chronic lymphedema post intervention: <italic toggle="yes">N</italic> = 22; chronic lymphedema without intervention: <italic toggle="yes">N</italic> = 23.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <sec id="cncr34377-sec-0015">
                  <title>Treatment‐related factors</title>
                  <p>Statistically significant effects were observed for having ALND (<italic toggle="yes">p</italic> &lt; .001) and taxane‐based chemotherapy (<italic toggle="yes">p</italic> &lt; .001) (Table <xref rid="cncr34377-tbl-0001" ref-type="table">1</xref>). Detailed investigation of the ALND effect found a significantly lower percentage of patients in the no lymphedema group had ALND (13.3%) than those in any of the other three outcome groups. A lower percentage of those who developed subclinical lymphedema but did not progress to chronic lymphedema had ALND than either of the chronic lymphedema groups (25.1% vs. &gt;55%, <italic toggle="yes">p</italic> &lt; .008). A lower percentage (33.6%) of the patients who had no lymphedema received taxane‐based chemotherapy than did those in the chronic lymphedema outcome groups (progression to chronic lymphedema after intervention, 70%; progression to chronic lymphedema with intervention, 70%; progression to chronic lymphedema without intervention, 59%, <italic toggle="yes">p</italic> &lt; .001) (Table <xref rid="cncr34377-tbl-0001" ref-type="table">1</xref>). Finally, within the treatment factors, if a patient had any radiation therapy, there were statistically significant differences in outcome for RNI. Again, within the group that did not have any evidence of lymphedema, the percentage of patients who had received RNI was significantly lower than the percentage in both of the chronic lymphedema outcome groups (23.6% [no lymphedema] vs. [chronic lymphedema] groups: 50.0% [following intervention], 47.8% [without intervention], <italic toggle="yes">p</italic> &lt; .008). Notably, neither mastectomy nor postoperative seromas were statistically significantly associated with the outcome (<italic toggle="yes">p</italic> &gt; .05) (Table <xref rid="cncr34377-tbl-0001" ref-type="table">1</xref>).</p>
                </sec>
                <sec id="cncr34377-sec-0016">
                  <title>Demographic, comorbid, and lifestyle factors</title>
                  <p>No statistically significant outcome associations were observed for age or for the comorbid factors of hypertension, diabetes, or smoking (<italic toggle="yes">p</italic> &gt; .20) (Table <xref rid="cncr34377-tbl-0001" ref-type="table">1</xref>). Compared with the other outcome groups, the highest BMI values were in the group who progressed to chronic lymphedema without receiving the compression intervention (<italic toggle="yes">p</italic> = .002). Rurality was significantly associated with outcome because a higher percentage of the patients who progressed to chronic lymphedema without the intervention lived in rural areas (46.2%) than those that had no lymphedema (22.2%) or those that received an intervention but did not progress to chronic lymphedema (21.9%) (<italic toggle="yes">p</italic> &lt; .008) (Table <xref rid="cncr34377-tbl-0001" ref-type="table">1</xref>).</p>
                  <p>Controlling for the opportunity for air travel before the end‐of‐study, no statistically significant association of simply flying (any air travel) was observed with the outcome (<italic toggle="yes">p</italic> = .365). However, if a patient did fly, the total number of flights (with or without prophylactic compression) was significantly associated with outcome. The direction of the effect, however, was not on increasing the likelihood of chronic lymphedema, rather it was in the direction of decreasing it (<italic toggle="yes">p</italic> &lt; .001). The median number of flights before chronic lymphedema for both groups of patients who progressed was considerably lower (postintervention: median = 2.0, IQR = 1, 4; without intervention: median = 3.5, IQR = 2, 9) than those who underwent the intervention but did not progress to chronic lymphedema (median = 7.0, IQR = 4, 14) (<italic toggle="yes">p</italic> &lt; .008). The number of flights without use of compression was lower in the group with chronic lymphedema after receiving the intervention than each of the other groups (median = 1.0, IQR = 0, 2; other groups: median ≥ 3.5) (<italic toggle="yes">p</italic> &lt; .008) (Table <xref rid="cncr34377-tbl-0002" ref-type="table">2</xref>). Furthermore, a drill‐down within the two groups of patients who met the criteria for subclinical lymphedema revealed no statistically significant differences between them either in the total number of flights or in number of flights without compression before intervention nor after intervention (<italic toggle="yes">p</italic> &gt; .10, Table <xref rid="cncr34377-tbl-0002" ref-type="table">2</xref>).</p>
                  <table-wrap position="float" id="cncr34377-tbl-0002" content-type="TABLE">
                    <label>TABLE 2</label>
                    <caption>
                      <p>Air travel by outcome group (<italic toggle="no">N</italic> = 918)</p>
                    </caption>
                    <table frame="hsides" rules="groups">
                      <col align="left" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <col align="center" span="1"/>
                      <thead>
                        <tr style="border-bottom:solid 1px #000000">
                          <th align="left" rowspan="1" colspan="1"/>
                          <th align="left" rowspan="1" colspan="1">
                            <p>No lymphedema</p>
                            <p>(<italic toggle="yes">N</italic> = 670)</p>
                          </th>
                          <th align="left" rowspan="1" colspan="1">
                            <p>Subclinical lymphedema</p>
                            <p>(<italic toggle="yes">N</italic> = 179)</p>
                          </th>
                          <th align="left" rowspan="1" colspan="1">Chronic lymphedema after intervention (<italic toggle="yes">N</italic> = 30)</th>
                          <th align="left" rowspan="1" colspan="1">
                            <p>Chronic lymphedema without intervention</p>
                            <p>(<italic toggle="yes">N</italic> = 39)</p>
                          </th>
                          <th align="left" rowspan="1" colspan="1">
                            <italic toggle="yes">p</italic>
                          </th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" colspan="6" style="background-color:#D0CECE" rowspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td colspan="4" align="center" rowspan="1">Median [IQR]</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Months on study</td>
                          <td align="center" rowspan="1" colspan="1">33.1 [25, 35] <sup>a</sup>
</td>
                          <td align="center" rowspan="1" colspan="1">33.0 [23, 35]<sup>a</sup>
</td>
                          <td align="center" rowspan="1" colspan="1">16.0 [8, 25] <sup>b</sup>
</td>
                          <td align="center" rowspan="1" colspan="1">8.2 [1, 27] <sup>b</sup>
</td>
                          <td align="center" rowspan="1" colspan="1">&lt;.001</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td colspan="3" align="center" rowspan="1">No. (%)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <italic toggle="yes">p</italic>
                            <xref rid="cncr34377-note-0007" ref-type="table-fn">*</xref>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Any air travel</td>
                          <td align="center" rowspan="1" colspan="1">456 (68.2)</td>
                          <td align="center" rowspan="1" colspan="1">117 (65.4)</td>
                          <td align="center" rowspan="1" colspan="1">11 (36.7)</td>
                          <td align="center" rowspan="1" colspan="1">18 (47.4)</td>
                          <td align="center" rowspan="1" colspan="1">.365</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Missing</td>
                          <td align="center" rowspan="1" colspan="1">1</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1">1</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">If travel:</td>
                          <td colspan="3" align="center" rowspan="1">Median [IQR] (Min, Max)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">No. of flights</td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>6.0 [3, 11]<sup>a</sup>
</p>
                            <p>(1, 78)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>7.0 [4, 14]<sup>b</sup>
</p>
                            <p>(1, 107)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>2.0 [1, 4]<sup>a</sup>
</p>
                            <p>(1, 6)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>3.5 [2, 9]<sup>a</sup>
</p>
                            <p>(2, 21)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">&lt;.001</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Missing</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1">1</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">No. of flights without compression</td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>5.0 [2, 10]<sup>a</sup>
</p>
                            <p>(0, 78)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>4.0 [1, 8]<sup>a</sup>
</p>
                            <p>(0, 46)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>1.0 [0, 2]<sup>b</sup>
</p>
                            <p>(0, 4)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>3.5 [2, 9]<sup>a</sup>
</p>
                            <p>(0, 21)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">&lt;.001</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Missing</td>
                          <td align="center" rowspan="1" colspan="1">1</td>
                          <td align="center" rowspan="1" colspan="1">1</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1">0</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td style="background-color:#D0CECE" align="left" rowspan="1" colspan="1">Before intervention</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td colspan="3" align="center" rowspan="1">Median [IQR]</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Months to trigger</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">7.6 [1, 17]</td>
                          <td align="center" rowspan="1" colspan="1">3.7 [1, 8]</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">.007</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td colspan="3" align="center" rowspan="1">No. (%)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Any air travel</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">70 (39.1)</td>
                          <td align="center" rowspan="1" colspan="1">4 (13.3)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">.090</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">If travel:</td>
                          <td colspan="3" align="center" rowspan="1">Median [IQR] (Min, Max)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">No. of flights</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <p>4.0 [2, 8]</p>
                            <p>(1, 89)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>2.5 [1, 6]</p>
                            <p>(1, 6)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">.227</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">No. of flights without compression</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <p>4.0 [2, 7]</p>
                            <p>(0, 34)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>1.5 [1, 4]</p>
                            <p>(1, 4)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">.111</td>
                        </tr>
                        <tr>
                          <td style="background-color:#D0CECE" align="left" rowspan="1" colspan="1">After intervention</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td colspan="3" align="center" rowspan="1">Median [IQR]</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Months to last assessment</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">18.2 [5, 30]</td>
                          <td align="center" rowspan="1" colspan="1">9.6 [4, 17]</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">.026</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1"/>
                          <td colspan="3" align="center" rowspan="1">No. (%)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">Any air travel</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">91 (50.8)</td>
                          <td align="center" rowspan="1" colspan="1">7 (23.3)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">.072</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">If travel:</td>
                          <td colspan="3" align="center" rowspan="1">Median [IQR] (Min, Max)</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">No. of flights</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <p>6.0 [2, 11]</p>
                            <p>(1, 73)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>2.0 [1, 4]</p>
                            <p>(1, 4)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">.104</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">No. of flights without compression</td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">
                            <p>2.0 [0, 4]</p>
                            <p>(0, 40)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1">
                            <p>0.0 [0, 2]</p>
                            <p>(0, 2)</p>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1">.171</td>
                        </tr>
                      </tbody>
                    </table>
                    <table-wrap-foot id="cncr34377-ntgp-0003">
                      <fn id="cncr34377-note-0005">
                        <p>Abbreviation: IQR, interquartile range.</p>
                      </fn>
                      <fn id="cncr34377-note-0006">
                        <label>
                          <sup>a,b,c</sup>
                        </label>
                        <p>Statistically significant differences between the outcome group (Bonferroni‐corrected, <italic toggle="yes">p</italic> &lt; .008).</p>
                      </fn>
                      <fn id="cncr34377-note-0007">
                        <label>*</label>
                        <p><italic toggle="yes">p</italic> value after controlling for months on study.</p>
                      </fn>
                    </table-wrap-foot>
                  </table-wrap>
                </sec>
              </sec>
            </sec>
            <sec sec-type="discussion" id="cncr34377-sec-0017">
              <title>DISCUSSION</title>
              <p>To the best of our knowledge, this study represents the most comprehensive, prospective examination of BCRL risk factors to date. Findings should be considered in light of both the strengths and weaknesses of the study. Strengths include overall sample size, length of follow‐up, international setting, and 22% rural representation. Limitations include insufficient sample size with small number progressing to complex decongestive physiotherapy (CDP) to conduct multivariate analyses. More frequent assessments may have led to more interventions for the 39 patients who progressed between visits; however, it is unknown if those patients met the criteria for intervention and bringing patients into clinical settings for more frequent lymphedema monitoring assessments is problematic because of patient and clinic burden and cost. Overall, the BIS group in the parent study had statistically significant less progression to CDP compared with TM,<xref rid="cncr34377-bib-0007" ref-type="bibr"><sup>7</sup></xref> and preliminary research has established that lymphedema home‐based self‐monitoring is feasible using BIS technology.<xref rid="cncr34377-bib-0045" ref-type="bibr"><sup>45</sup></xref>, <xref rid="cncr34377-bib-0046" ref-type="bibr"><sup>46</sup></xref> Future research should explore the use of various forms of home monitoring as a component of a PSEI model of care for individuals at higher risk.</p>
              <p>Study findings relating to treatment modalities, comorbid conditions, and lifestyle practices as risk factors have significant implications for the PSEI model and clinical care. Regarding treatment, patients undergoing ALND, RNI, and taxane‐based chemotherapy remain at higher risk for chronic lymphedema than others do, even after receiving a preventive compression intervention at onset of subclinical lymphedema. The ALND and RNI findings are consistent with previous research that found less treatment to the axilla (sentinel node biopsy alone) was associated with less incidence of subclinical BCRL than more extensive treatment (ALND or radiation that included level 3 of the axilla or supraclavicular fossa).<xref rid="cncr34377-bib-0047" ref-type="bibr"><sup>47</sup></xref> The taxane finding is not surprising because taxane‐based chemotherapy was the predominant chemotherapy administered in this study, yet these results contrast with findings from another large prospective study in this population in which taxane‐based chemotherapy was not found to be a risk factor.<xref rid="cncr34377-bib-0048" ref-type="bibr"><sup>48</sup></xref> The findings do, however, support other findings regarding taxanes as a risk factor.<xref rid="cncr34377-bib-0013" ref-type="bibr"><sup>13</sup></xref>
</p>
              <p>Comorbidities such as age, BMI, hypertension, smoking, or diabetes as risk factors in the presence of identified and immediately treated subclinical BCRL were minimal. Only BMI emerged as a risk factor, and the highest BMI values were in the group that progressed to chronic lymphedema without receiving the compression intervention.</p>
              <p>Lifestyle factor findings are also informative. Rurality was found to be a risk factor. As with BMI, the highest number of rural dwellers were in the group that progressed to chronic lymphedema without receiving the compression intervention. These findings suggest that obesity and rurality should be considered high risk factors for chronic lymphedema development within the first year postoperatively. To afford these individuals an option for a preventive intervention likely requires more frequent monitoring than every 3 months, as was done in this study. These findings suggest that the PSEI with subclinical BCRL intervention may serve as a vital safety net for BCS residing in underresourced rural areas. Smoking was not found to be a protective lifestyle factor, and this finding in our large sample stands in contrast with a previous study that suggested smoking might be protective against chronic BCRL.<xref rid="cncr34377-bib-0032" ref-type="bibr"><sup>32</sup></xref> Our findings also provided new evidence to support clinicians when addressing air travel/flying as a risk factor. In this study of women participating in PSEI, air travel was not a lymphedema risk factor (statistical significance in favor of flying). It is unknown however if patients who received the intervention subsequently limited flying out of concern for increased risk of developing chronic BCRL. Behavioral research regarding self‐restrictive behaviors after intervention in the PSEI process would be illuminating. However, the need to restrict air travel in this distinct patient population was not reinforced in this study and, as such, does lend support to the National Comprehensive Cancer Network's Lymphedema Guidelines that suggest flying is not likely a risk factor.<xref rid="cncr34377-bib-0049" ref-type="bibr"><sup>49</sup></xref> Caution is warranted, however, when considering whether to advise patients without lymphedema to wear prophylactic compression garments when flying because our findings do not demonstrate patient benefit.</p>
              <p>In general, patients who have any of the high‐risk factors identified in this study may benefit from lymphedema assessment between routine cancer follow‐up appointments, perhaps in the form of home self‐monitoring. This is especially true for obese and rural dwelling patients. Risk reduction education should be targeted according to the current evidence and level of risk and encourage active patient participation in PSEI for the duration of the monitoring period. Finally, patients in this study were seen in high‐volume cancer clinics by trained research staff who performed the measures and initiated an intervention.<xref rid="cncr34377-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="cncr34377-bib-0007" ref-type="bibr"><sup>7</sup></xref>, <xref rid="cncr34377-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="cncr34377-bib-0009" ref-type="bibr"><sup>9</sup></xref> This demonstrates that the PSEI model is not dependent on trained lymphedema therapists for successful outcomes and that referrals to certified lymphedema therapists when patients progress after subclinical intervention may be best practice. The breast cancer multidisciplinary treatment team is well positioned to be trained to independently conduct prospective surveillance and implement compression interventions for subclinical BCRL and thus improve patient outcomes.</p>
              <p>In conclusion, within 3 years of PSEI with compression intervention for subclinical BCRL, treatment‐related variables of ALND, taxane‐based chemotherapy, and RNI increased lymphedema risk. A BMI &gt;30 or residing in rural areas may place individuals at risk for very early development of chronic lymphedema. The study findings support the value of the PSEI model of care for successful management of subclinical BCRL not only to lymphedema prevention, but also in risk reduction education and as galvanizing for quality of life and empowerment in BCS.</p>
            </sec>
            <sec id="cncr34377-sec-0018">
              <title>AUTHOR CONTRIBUTIONS</title>
              <p><bold>Louise A. Koelmeyer:</bold> Methodology, resources, writing–review and editing, conceptualization and original draft, investigation, and project administration. <bold>Katrina Gaitatzis:</bold> Conceptualization and original draft, methodology, resources, writing–review and editing, investigation, and project administration. <bold>Mary S. Dietrich:</bold> Conceptualization and original draft, validation, methodology, resources, verification of underlying data, data curation, formal analysis, and writing–review and editing. <bold>Chirag S. Shah:</bold> Methodology, resources, writing–review and editing, and validation. <bold>John Boyages:</bold> Methodology, resources, writing–review and editing, investigation, and project administration. <bold>Sarah A. McLaughlin:</bold> Methodology, resources, writing–review and editing, investigation, and project administration. <bold>Bret Taback:</bold> Methodology, resources, writing–review and editing, investigation, and project administration. <bold>Deonni P. Stolldorf:</bold> Methodology, resources, writing–review and editing, investigation, and project administration. <bold>Elisabeth Elder:</bold> Methodology, resources, and writing–review and editing. <bold>T. Michael Hughes:</bold> Methodology, resources, and writing–review and editing. <bold>James R. French:</bold> Methodology, resources, and writing–review and editing. <bold>Nicholas Ngui:</bold> Methodology, resources, and writing–review and editing. <bold>Jeremy M. Hsu:</bold> Methodology, resources, and writing–review and editing. <bold>Andrew Moore:</bold> Methodology, resources, writing–review and editing, investigation, and project administration. <bold>Sheila H. Ridner:</bold> Conceptualization and writing original draft, methodology, resources, writing–review and editing, verification of underlying data, data curation, formal analysis, validation, investigation, and project administration.</p>
            </sec>
            <sec id="cncr34377-sec-0020">
              <title>FUNDING INFORMATION</title>
              <p>ImpediMed, medi, and the National Institutes of Health (NIH/NCATS UL1 TR000445).</p>
            </sec>
            <sec sec-type="COI-statement" id="cncr34377-sec-0021">
              <title>CONFLICTS OF INTEREST</title>
              <p>Louise A. Koelmeyer reports serving as an education consultant for ImpediMed. Chirag S. Shah reports serving as a consultant for ImpediMed, PreludeDX, and Evicore and receiving grants from Varian Medical Systems and PreludeDX. John Boyages is a stockholder in ImpediMed.</p>
            </sec>
          </body>
          <back>
            <ack id="cncr34377-sec-0019">
              <title>ACKNOWLEDGMENTS</title>
              <p>We thank the multidisciplinary teams and women who participated in the study for 3 years. This study was supported by ImpediMed, medi, and the National Institutes of Health (NIH/NCATS UL1 TR000445).</p>
            </ack>
            <ref-list content-type="cited-references" id="cncr34377-bibl-0001">
              <title>REFERENCES</title>
              <ref id="cncr34377-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0001"><string-name><surname>McLaughlin</surname><given-names>SA</given-names></string-name>, <string-name><surname>Brunelle</surname><given-names>CL</given-names></string-name>, <string-name><surname>Taghian</surname><given-names>A</given-names></string-name>. <article-title>Breast cancer‐related lymphedema: risk factors, screening, management, and the impact of locoregional treatment</article-title>. <source>J Clin Oncol</source>. <year>2020</year>;<volume>38</volume>(<issue>20</issue>):<fpage>2341</fpage>‐<lpage>2350</lpage>. doi:<pub-id pub-id-type="doi">10.1200/JCO.19.02896</pub-id>
<pub-id pub-id-type="pmid">32442064</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0002"><string-name><surname>Bevilacqua</surname><given-names>JL</given-names></string-name>, <string-name><surname>Kattan</surname><given-names>MW</given-names></string-name>, <string-name><surname>Changhong</surname><given-names>Y</given-names></string-name>, et al. <article-title>Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer</article-title>. <source>Ann Surg Oncol</source>. <year>2012</year>;<volume>19</volume>(<issue>8</issue>):<fpage>2580</fpage>‐<lpage>2589</lpage>. doi:<pub-id pub-id-type="doi">10.1245/s10434-012-2290-x</pub-id>
<pub-id pub-id-type="pmid">22395997</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0003"><string-name><surname>Koelmeyer</surname><given-names>LA</given-names></string-name>, <string-name><surname>Borotkanics</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Alcorso</surname><given-names>J</given-names></string-name>, et al. <article-title>Early surveillance is associated with less incidence and severity of breast cancer‐related lymphedema compared with a traditional referral model of care</article-title>. <source>Cancer</source>. <year>2019</year>;<volume>125</volume>(<issue>6</issue>):<fpage>854</fpage>‐<lpage>862</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cncr.31873</pub-id>
<pub-id pub-id-type="pmid">30521080</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0004"><string-name><surname>McLaughlin</surname><given-names>SA</given-names></string-name>, <string-name><surname>Stout</surname><given-names>NL</given-names></string-name>, <string-name><surname>Schaverien</surname><given-names>MV</given-names></string-name>. <article-title>Avoiding the swell: advances in lymphedema prevention, detection, and management</article-title>. <source>Am Soc Clin Oncol Educ Book</source>. <year>2020</year>;<volume>40</volume>:<fpage>1</fpage>‐<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.1200/EDBK_280471</pub-id>
</mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0005"><string-name><surname>Hayes</surname><given-names>SC</given-names></string-name>, <string-name><surname>Johansson</surname><given-names>K</given-names></string-name>, <string-name><surname>Stout</surname><given-names>NL</given-names></string-name>, et al. <article-title>Upper‐body morbidity after breast cancer: Incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care</article-title>. <source>Cancer</source>. <year>2012</year>;<volume>118</volume>(<issue>8 suppl</issue>):<fpage>2237</fpage>‐<lpage>2249</lpage>. doi:<pub-id pub-id-type="doi">10.1002/cncr.27467</pub-id>
<pub-id pub-id-type="pmid">22488698</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0006"><string-name><surname>Koelmeyer</surname><given-names>L</given-names></string-name>, <string-name><surname>Gaitatzis</surname><given-names>K</given-names></string-name>, <string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, et al. <article-title>Implementing a prospective surveillance and early intervention model of care for breast cancer‐related lymphedema into clinical practice: application of the RE‐AIM framework</article-title>. <source>Support Care Cancer</source>. <year>2021</year>;<volume>29</volume>(<issue>2</issue>):<fpage>1081</fpage>‐<lpage>1089</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00520-020-05597-5</pub-id>
<pub-id pub-id-type="pmid">32613370</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0007"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>MS</given-names></string-name>, <string-name><surname>Boyages</surname><given-names>J</given-names></string-name>, et al. <article-title>A comparison of bioimpedance spectroscopy or tape measure triggered compression intervention in chronic breast cancer lymphedema prevention</article-title><source>Lymphat Res Biol</source> Published online January <volume>28</volume>, <year>2022</year>:<fpage>1</fpage>‐<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1089/lrb.2021.00841</pub-id>
</mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0008"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>MS</given-names></string-name>, <string-name><surname>Spotanski</surname><given-names>K</given-names></string-name>, et al. <article-title>A prospective study of L‐Dex values in breast cancer patients pretreatment and through 12 months postoperatively</article-title>. <source>Lymphat Res Biol</source>. <year>2018</year>;<volume>16</volume>(<issue>5</issue>):<fpage>435</fpage>‐<lpage>441</lpage>. doi:<pub-id pub-id-type="doi">10.1089/lrb.2017.0070</pub-id>
<pub-id pub-id-type="pmid">30130147</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0009"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>MS</given-names></string-name>, <string-name><surname>Cowher</surname><given-names>MS</given-names></string-name>, et al. <article-title>A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis</article-title>. <source>Ann Surg Oncol</source>. <year>2019</year>;<volume>26</volume>(<issue>10</issue>):<fpage>3250</fpage>‐<lpage>3259</lpage>. doi:<pub-id pub-id-type="doi">10.1245/s10434-019-07344-5</pub-id>
<pub-id pub-id-type="pmid">31054038</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0010"><string-name><surname>Miller</surname><given-names>CL</given-names></string-name>, <string-name><surname>Specht</surname><given-names>MC</given-names></string-name>, <string-name><surname>Skolny</surname><given-names>MN</given-names></string-name>, et al. <article-title>Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients</article-title>. <source>Breast Cancer Res Treat</source>. <year>2014</year>;<volume>144</volume>(<issue>1</issue>):<fpage>71</fpage>‐<lpage>77</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10549-014-2856-3</pub-id>
<pub-id pub-id-type="pmid">24500108</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0011"><string-name><surname>Naoum</surname><given-names>GE</given-names></string-name>, <string-name><surname>Roberts</surname><given-names>S</given-names></string-name>, <string-name><surname>Brunelle</surname><given-names>CL</given-names></string-name>, et al. <article-title>Quantifying the impact of axillary surgery and nodal irradiation on breast cancer‐related lymphedema and local tumor control: long‐term results from a prospective screening trial</article-title>. <source>J Clin Oncol</source>. <year>2020</year>;<volume>38</volume>(<issue>29</issue>):<fpage>3430</fpage>‐<lpage>3438</lpage>. doi:<pub-id pub-id-type="doi">10.1200/JCO.20.00459</pub-id>
<pub-id pub-id-type="pmid">32730184</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0012"><string-name><surname>Gross</surname><given-names>JP</given-names></string-name>, <string-name><surname>Whelan</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Parulekar</surname><given-names>WR</given-names></string-name>, et al. <article-title>Development and validation of a nomogram to predict lymphedema after axillary surgery and radiation therapy in women with breast cancer from the NCIC CTG MA.20 randomized trial</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. <year>2019</year>;<volume>105</volume>(<issue>1</issue>):<fpage>165</fpage>‐<lpage>173</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijrobp.2019.05.002</pub-id>
<pub-id pub-id-type="pmid">31085285</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0013"><string-name><surname>Lee</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Beith</surname><given-names>J</given-names></string-name>, <string-name><surname>Ward</surname><given-names>L</given-names></string-name>, <string-name><surname>Kilbreath</surname><given-names>S</given-names></string-name>. <article-title>Lymphedema following taxane‐based chemotherapy in women with early breast cancer</article-title>. <source>Lymphat Res Biol</source>. <year>2014</year>;<volume>12</volume>(<issue>4</issue>):<fpage>282</fpage>‐<lpage>288</lpage>. doi:<pub-id pub-id-type="doi">10.1089/lrb.2014.0030</pub-id>
<pub-id pub-id-type="pmid">25411764</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0014"><string-name><surname>Gartner</surname><given-names>R</given-names></string-name>, <string-name><surname>Jensen</surname><given-names>MB</given-names></string-name>, <string-name><surname>Kronborg</surname><given-names>L</given-names></string-name>, <string-name><surname>Ewertz</surname><given-names>M</given-names></string-name>, <string-name><surname>Kehlet</surname><given-names>H</given-names></string-name>, <string-name><surname>Kroman</surname><given-names>N</given-names></string-name>. <article-title>Self‐reported arm‐lymphedema and functional impairment after breast cancer treatment—a nationwide study of prevalence and associated factors</article-title>. <source>Breast</source>. <year>2010</year>;<volume>19</volume>(<issue>6</issue>):<fpage>506</fpage>‐<lpage>515</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.breast.2010.05.015</pub-id>
<pub-id pub-id-type="pmid">20561790</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0015"><string-name><surname>Kilbreath</surname><given-names>SL</given-names></string-name>, <string-name><surname>Refshauge</surname><given-names>KM</given-names></string-name>, <string-name><surname>Beith</surname><given-names>JM</given-names></string-name>, et al. <article-title>Risk factors for lymphoedema in women with breast cancer: a large prospective cohort</article-title>. <source>Breast</source>. <year>2016</year>;<volume>28</volume>:<fpage>29</fpage>‐<lpage>36</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.breast.2016.04.011</pub-id>
<pub-id pub-id-type="pmid">27183497</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0016"><string-name><surname>Fontaine</surname><given-names>C</given-names></string-name>, <string-name><surname>Van Parijs</surname><given-names>H</given-names></string-name>, <string-name><surname>Decoster</surname><given-names>L</given-names></string-name>. <article-title>A prospective analysis of the incidence of postoperative lymphedema 1 to 2 years after surgery and axillary dissection in early breast cancer (BC) patients treated with concomitant irradiation and anthracyclines followed by paclitaxel</article-title>. <source>J Clin Oncol</source>. <year>2010</year>;<volume>28</volume>:<elocation-id>e11059</elocation-id>. doi:<pub-id pub-id-type="doi">10.1200/jco.2010.28.15_suppl.e11059</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0017"><string-name><surname>Norman</surname><given-names>SA</given-names></string-name>, <string-name><surname>Localio</surname><given-names>AR</given-names></string-name>, <string-name><surname>Kallan</surname><given-names>MJ</given-names></string-name>, et al. <article-title>Risk factors for lymphedema after breast cancer treatment</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source>. <year>2010</year>;<volume>19</volume>(<issue>11</issue>):<fpage>2734</fpage>‐<lpage>2746</lpage>. doi:<pub-id pub-id-type="doi">10.1158/1055-9965.epi-09-1245</pub-id>
<pub-id pub-id-type="pmid">20978176</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0018"><string-name><surname>Hashemi</surname><given-names>E</given-names></string-name>, <string-name><surname>Kaviani</surname><given-names>A</given-names></string-name>, <string-name><surname>Najafi</surname><given-names>M</given-names></string-name>, <string-name><surname>Ebrahimi</surname><given-names>M</given-names></string-name>, <string-name><surname>Hooshmand</surname><given-names>H</given-names></string-name>, <string-name><surname>Montazeri</surname><given-names>A</given-names></string-name>. <article-title>Seroma formation after surgery for breast cancer</article-title>. <source>World J Surg Oncol</source>. <year>2004</year>;<volume>2</volume>:<fpage>44</fpage>. doi:<pub-id pub-id-type="doi">10.1186/1477-7819-2-44</pub-id><pub-id pub-id-type="pmid">15588301</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0019"><string-name><surname>Fu</surname><given-names>MR</given-names></string-name>, <string-name><surname>Guth</surname><given-names>AA</given-names></string-name>, <string-name><surname>Cleland</surname><given-names>CM</given-names></string-name>, et al. <article-title>The effects of symptomatic seroma on lymphedema symptoms following breast cancer treatment</article-title>. <source>Lymphology</source>. <year>2011</year>;<volume>44</volume>(<issue>3</issue>):<fpage>134</fpage>‐<lpage>143</lpage>.<pub-id pub-id-type="pmid">22165584</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0020"><string-name><surname>Troost</surname><given-names>MS</given-names></string-name>, <string-name><surname>Kempees</surname><given-names>CJ</given-names></string-name>, <string-name><surname>de Roos</surname><given-names>MAJ</given-names></string-name>. <article-title>Breast cancer surgery without drains: No influence on seroma formation</article-title>. <source>Int J Surg</source>. <year>2015</year>;<volume>13</volume>:<fpage>170</fpage>‐<lpage>174</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijsu.2014.11.050</pub-id>
<pub-id pub-id-type="pmid">25486263</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0021"><string-name><surname>Kuroi</surname><given-names>K</given-names></string-name>, <string-name><surname>Shimozuma</surname><given-names>K</given-names></string-name>, <string-name><surname>Taguchi</surname><given-names>T</given-names></string-name>, et al. <article-title>Evidence‐based risk factors for seroma formation in breast surgery</article-title>. <source>Jpn J Clin Oncol</source>. <year>2006</year>;<volume>36</volume>(<issue>4</issue>):<fpage>197</fpage>‐<lpage>206</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jjco/hyl019</pub-id>
<pub-id pub-id-type="pmid">16684859</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0022"><string-name><surname>Toyserkani</surname><given-names>NM</given-names></string-name>, <string-name><surname>Jorgensen</surname><given-names>MG</given-names></string-name>, <string-name><surname>Haugaard</surname><given-names>K</given-names></string-name>, <string-name><surname>Sorensen</surname><given-names>JA</given-names></string-name>. <article-title>Seroma indicates increased risk of lymphedema following breast cancer treatment: a retrospective cohort study</article-title>. <source>Breast</source>. <year>2017</year>;<volume>32</volume>:<fpage>102</fpage>‐<lpage>104</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.breast.2017.01.009</pub-id>
<pub-id pub-id-type="pmid">28129628</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0023"><string-name><surname>Monleon</surname><given-names>S</given-names></string-name>, <string-name><surname>Murta‐Nascimento</surname><given-names>C</given-names></string-name>, <string-name><surname>Bascuas</surname><given-names>I</given-names></string-name>, <string-name><surname>Macia</surname><given-names>F</given-names></string-name>, <string-name><surname>Duarte</surname><given-names>E</given-names></string-name>, <string-name><surname>Belmonte</surname><given-names>R</given-names></string-name>. <article-title>Lymphedema predictor factors after breast cancer surgery: a survival analysis</article-title>. <source>Lymphat Res Biol</source>. <year>2015</year>;<volume>13</volume>(<issue>4</issue>):<fpage>268</fpage>‐<lpage>274</lpage>. doi:<pub-id pub-id-type="doi">10.1089/lrb.2013.0042</pub-id>
<pub-id pub-id-type="pmid">24837643</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0024"><string-name><surname>Saleh</surname><given-names>HA</given-names></string-name>, <string-name><surname>Rageh</surname><given-names>TM</given-names></string-name>, <string-name><surname>Alhassanin</surname><given-names>SA</given-names></string-name>, <string-name><surname>Megahed</surname><given-names>MA</given-names></string-name>. <article-title>Upper limb lymphedema related to breast cancer therapy: incidence, risk factors, diagnostic techniques, risk reduction and optimal management</article-title>. <source>Int Surg J</source>. <year>2018</year>;<volume>5</volume>(<issue>11</issue>):<fpage>3633</fpage>. doi:<pub-id pub-id-type="doi">10.18203/2349-2902.isj20184636</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0025"><string-name><surname>Leray</surname><given-names>H</given-names></string-name>, <string-name><surname>Malloizel‐Delaunay</surname><given-names>J</given-names></string-name>, <string-name><surname>Lusque</surname><given-names>A</given-names></string-name>, et al. <article-title>Body mass index as a major risk factor for severe breast cancer‐related lymphedema</article-title>. <source>Lymphat Res Biol</source>. <year>2020</year>;<volume>18</volume>(<issue>6</issue>):<fpage>510</fpage>‐<lpage>516</lpage>. doi:<pub-id pub-id-type="doi">10.1089/lrb.2019.0009</pub-id>
<pub-id pub-id-type="pmid">32283042</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0026"><string-name><surname>Togawa</surname><given-names>K</given-names></string-name>, <string-name><surname>Ma</surname><given-names>H</given-names></string-name>, <string-name><surname>Sullivan‐Halley</surname><given-names>J</given-names></string-name>, et al. <article-title>Risk factors for self‐reported arm lymphedema among female breast cancer survivors: a prospective cohort study</article-title>. <source>Breast Cancer Res</source>. <year>2014</year>;<volume>16</volume>(<issue>4</issue>):<fpage>414</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s13058-014-0414-x</pub-id><pub-id pub-id-type="pmid">25145603</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0027"><string-name><surname>Zou</surname><given-names>L</given-names></string-name>, <string-name><surname>Liu</surname><given-names>FH</given-names></string-name>, <string-name><surname>Shen</surname><given-names>PP</given-names></string-name>, et al. <article-title>The incidence and risk factors of related lymphedema for breast cancer survivors post‐operation: a 2‐year follow‐up prospective cohort study</article-title>. <source>Breast Cancer</source>. <year>2018</year>;<volume>25</volume>(<issue>3</issue>):<fpage>309</fpage>‐<lpage>314</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s12282-018-0830-3</pub-id>
<pub-id pub-id-type="pmid">29397555</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0028"><string-name><surname>Dominick</surname><given-names>SA</given-names></string-name>, <string-name><surname>Madlensky</surname><given-names>L</given-names></string-name>, <string-name><surname>Natarajan</surname><given-names>L</given-names></string-name>, <string-name><surname>Pierce</surname><given-names>JP</given-names></string-name>. <article-title>Risk factors associated with breast cancer‐related lymphedema in the WHEL study</article-title>. <source>J Cancer Surviv</source>. <year>2013</year>;<volume>7</volume>(<issue>1</issue>):<fpage>115</fpage>‐<lpage>123</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11764-012-0251-9</pub-id>
<pub-id pub-id-type="pmid">23212606</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0029"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>MS</given-names></string-name>. <article-title>Self‐reported comorbid conditions and medication usage in breast cancer survivors with and without lymphedema</article-title>. <source>Oncol Nurs Forum</source>. <year>2008</year>;<volume>35</volume>(<issue>1</issue>):<fpage>57</fpage>‐<lpage>63</lpage>. doi:<pub-id pub-id-type="doi">10.1188/08.ONF.57-63</pub-id>
<pub-id pub-id-type="pmid">18192153</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0030"><string-name><surname>Ozaslan</surname><given-names>C</given-names></string-name>, <string-name><surname>Kuru</surname><given-names>B</given-names></string-name>. <article-title>Lymphedema after treatment of breast cancer</article-title>. <source>Am J Surg</source>. <year>2004</year>;<volume>187</volume>(<issue>1</issue>):<fpage>69</fpage>‐<lpage>72</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.amjsurg.2002.12.003</pub-id>
<pub-id pub-id-type="pmid">14706589</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0031"><string-name><surname>Ugur</surname><given-names>S</given-names></string-name>, <string-name><surname>Arici</surname><given-names>C</given-names></string-name>, <string-name><surname>Yaprak</surname><given-names>M</given-names></string-name>, et al. <article-title>Risk factors of breast cancer‐related lymphedema</article-title>. <source>Lymphat Res Biol</source>. <year>2013</year>;<volume>11</volume>(<issue>2</issue>):<fpage>72</fpage>‐<lpage>75</lpage>. doi:<pub-id pub-id-type="doi">10.1089/lrb.2013.0004</pub-id>
<pub-id pub-id-type="pmid">23772716</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0032"><string-name><surname>Bedi</surname><given-names>M</given-names></string-name>, <string-name><surname>King</surname><given-names>DM</given-names></string-name>, <string-name><surname>Whitfield</surname><given-names>R</given-names></string-name>, et al. <article-title>The effect of smoking and major vein resection on post‐therapy lymphedema in soft tissue sarcomas treated with neoadjuvant radiation and limb‐salvage surgery</article-title>. <source>Am J Clin Oncol</source>. <year>2015</year>;<volume>38</volume>(<issue>2</issue>):<fpage>184</fpage>‐<lpage>188</lpage>. doi:<pub-id pub-id-type="doi">10.1097/COC.0b013e31828aadc9</pub-id>
<pub-id pub-id-type="pmid">23563214</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0033"><string-name><surname>McLaughlin</surname><given-names>SA</given-names></string-name>, <string-name><surname>Bagaria</surname><given-names>S</given-names></string-name>, <string-name><surname>Gibson</surname><given-names>T</given-names></string-name>, et al. <article-title>Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery</article-title>. <source>J Am Coll Surg</source>. <year>2013</year>;<volume>216</volume>(<issue>3</issue>):<fpage>380</fpage>‐<lpage>389</lpage>; quiz 511–383. doi:<pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2012.11.004</pub-id>
<pub-id pub-id-type="pmid">23266421</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0034"><string-name><surname>Co</surname><given-names>M</given-names></string-name>, <string-name><surname>Ng</surname><given-names>J</given-names></string-name>, <string-name><surname>Kwong</surname><given-names>A</given-names></string-name>. <article-title>Air travel safety in postoperative breast cancer patients: a systematic review</article-title>. <source>Clin Breast Cancer</source>. <year>2018</year>;<volume>18</volume>(<issue>5</issue>):<fpage>e813</fpage>‐<lpage>e817</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.clbc.2018.05.003</pub-id>
<pub-id pub-id-type="pmid">29859745</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0035"><string-name><surname>Casley‐Smith</surname><given-names>JR</given-names></string-name>. <article-title>Lymphedema initiated by aircraft flights</article-title>. <source>Aviat Space Environ Med</source>. <year>1996</year>;<volume>67</volume>(<issue>1</issue>):<fpage>52</fpage>‐<lpage>56</lpage>.<pub-id pub-id-type="pmid">8929203</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0036"><string-name><surname>Reid‐Arndt</surname><given-names>SA</given-names></string-name>, <string-name><surname>Cox</surname><given-names>CR</given-names></string-name>. <article-title>Does rurality affect quality of life following treatment for breast cancer?</article-title><source>J Rural Health</source>. <year>2010</year>;<volume>26</volume>(<issue>4</issue>):<fpage>402</fpage>‐<lpage>405</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1748-0361.2010.00295.x</pub-id>
<pub-id pub-id-type="pmid">21029176</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0037"><string-name><surname>Graham</surname><given-names>PH</given-names></string-name>. <article-title>Compression prophylaxis may increase the potential for flight‐associated lymphoedema after breast cancer treatment</article-title>. <source>Breast</source>. <year>2002</year>;<volume>11</volume>(<issue>1</issue>):<fpage>66</fpage>‐<lpage>71</lpage>. doi:<pub-id pub-id-type="doi">10.1054/brst.2001.0370</pub-id>
<pub-id pub-id-type="pmid">14965648</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="miscellaneous" id="cncr34377-cit-0038"><collab collab-type="authors">ImpediMed</collab>
. <article-title>L‐Dex U400 datasheet</article-title>. Published 2019. Accessed November 23, 2020. <ext-link xlink:href="http://impedimed.com/wp-content/uploads/2019/06/PM-039_Rev_E_L-Dex_U400_Datasheet.pdf" ext-link-type="uri">http://impedimed.com/wp‐content/uploads/2019/06/PM‐039_Rev_E_L‐Dex_U400_Datasheet.pdf</ext-link>
</mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="miscellaneous" id="cncr34377-cit-0039"><collab collab-type="authors">FitnessMart</collab>
. <article-title>Gulick II tape measure</article-title>. Country Technologies Inc. Published 2019. Accessed November 8, 2019. <ext-link xlink:href="https://www.fitnessmart.com/products/gulick-ii-tape-measure?variant=27555940167" ext-link-type="uri">https://www.fitnessmart.com/products/gulick‐ii‐tape‐measure?variant=27555940167</ext-link>
</mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0040"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>LD</given-names></string-name>, <string-name><surname>Hepworth</surname><given-names>JT</given-names></string-name>, <string-name><surname>Stewart</surname><given-names>BR</given-names></string-name>, <string-name><surname>Armer</surname><given-names>JM</given-names></string-name>. <article-title>Comparison of upper limb volume measurement techniques and arm symptoms between healthy volunteers and individuals with known lymphedema</article-title>. <source>Lymphology</source>. <year>2007</year>;<volume>40</volume>(<issue>1</issue>):<fpage>35</fpage>‐<lpage>46</lpage>.<pub-id pub-id-type="pmid">17539463</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0041"><string-name><surname>Czerniec</surname><given-names>SA</given-names></string-name>, <string-name><surname>Ward</surname><given-names>LC</given-names></string-name>, <string-name><surname>Refshauge</surname><given-names>KM</given-names></string-name>, et al. <article-title>Assessment of breast cancer‐related arm lymphedema—comparison of physical measurement methods and self‐report</article-title>. <source>Cancer Invest</source>. <year>2010</year>;<volume>28</volume>(<issue>1</issue>):<fpage>54</fpage>‐<lpage>62</lpage>. doi:<pub-id pub-id-type="doi">10.3109/07357900902918494</pub-id>
<pub-id pub-id-type="pmid">19916749</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0042"><string-name><surname>Fu</surname><given-names>MR</given-names></string-name>, <string-name><surname>Cleland</surname><given-names>CM</given-names></string-name>, <string-name><surname>Guth</surname><given-names>AA</given-names></string-name>, et al. <article-title>L‐dex ratio in detecting breast cancer‐related lymphedema: reliability, sensitivity, and specificity</article-title>. <source>Lymphology</source>. <year>2013</year>;<volume>46</volume>(<issue>2</issue>):<fpage>85</fpage>‐<lpage>96</lpage>.<pub-id pub-id-type="pmid">24354107</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0043"><string-name><surname>Taylor</surname><given-names>R</given-names></string-name>, <string-name><surname>Jayasinghe</surname><given-names>U</given-names></string-name>, <string-name><surname>Koelmeyer</surname><given-names>L</given-names></string-name>, <string-name><surname>Boyages</surname><given-names>J</given-names></string-name>, <string-name><surname>Ung</surname><given-names>O</given-names></string-name>. <article-title>Reliability and validity of arm volume measurements for assessment of lymphoedema</article-title>. <source>Phys Ther</source>. <year>2006</year>;<volume>86</volume>(<issue>2</issue>):<fpage>205</fpage>‐<lpage>214</lpage>.<pub-id pub-id-type="pmid">16445334</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0044"><string-name><surname>Koelmeyer</surname><given-names>LA</given-names></string-name>, <string-name><surname>Ward</surname><given-names>LC</given-names></string-name>, <string-name><surname>Dean</surname><given-names>C</given-names></string-name>, <string-name><surname>Boyages</surname><given-names>J</given-names></string-name>. <article-title>Body positional effects on bioimpedance spectroscopy measurements for lymphedema assessment of the arm</article-title>. <source>Lymph Res Biol</source>. <year>2020</year>;<volume>18</volume>(<issue>1</issue>):<fpage>1</fpage>‐<lpage>10</lpage>. doi:<pub-id pub-id-type="doi">10.1089/lrb.2019.0067</pub-id>
</mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0045">
                <label>45</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0045"><string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>, <string-name><surname>Shih</surname><given-names>YC</given-names></string-name>, <string-name><surname>Doersam</surname><given-names>JK</given-names></string-name>, <string-name><surname>Rhoten</surname><given-names>BA</given-names></string-name>, <string-name><surname>Schultze</surname><given-names>BS</given-names></string-name>, <string-name><surname>Dietrich</surname><given-names>MS</given-names></string-name>. <article-title>A pilot randomized trial evaluating lymphedema self‐measurement with bioelectrical impedance, self‐care adherence, and health outcomes</article-title>. <source>Lymphat Res Biol</source>. <year>2014</year>;<volume>12</volume>(<issue>4</issue>):<fpage>258</fpage>‐<lpage>266</lpage>. doi:<pub-id pub-id-type="doi">10.1089/lrb.2014.0017</pub-id>
<pub-id pub-id-type="pmid">25412401</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0046">
                <label>46</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0046"><string-name><surname>Koelmeyer</surname><given-names>LA</given-names></string-name>, <string-name><surname>Moloney</surname><given-names>E</given-names></string-name>, <string-name><surname>Boyages</surname><given-names>J</given-names></string-name>, <string-name><surname>Sherman</surname><given-names>KA</given-names></string-name>, <string-name><surname>Dean</surname><given-names>CM</given-names></string-name>. <article-title>Prospective surveillance model in the home for breast cancer‐related lymphoedema: a feasibility study</article-title>. <source>Breast Cancer Res Treat</source>. <year>2021</year>;<volume>185</volume>(<issue>2</issue>):<fpage>401</fpage>‐<lpage>412</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10549-020-05953-3</pub-id>
<pub-id pub-id-type="pmid">33006001</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0047">
                <label>47</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0047"><string-name><surname>Boyages</surname><given-names>J</given-names></string-name>, <string-name><surname>Vicini</surname><given-names>FA</given-names></string-name>, <string-name><surname>Shah</surname><given-names>C</given-names></string-name>, <string-name><surname>Koelmeyer</surname><given-names>LA</given-names></string-name>, <string-name><surname>Nelms</surname><given-names>JA</given-names></string-name>, <string-name><surname>Ridner</surname><given-names>SH</given-names></string-name>. <article-title>The risk of subclinical breast cancer‐related lymphedema by the extent of axillary surgery and regional node irradiation: a randomized controlled trial</article-title>. <source>Int J Radiat Oncol Biol Phys</source>. <year>2021</year>;<volume>109</volume>(<issue>4</issue>):<fpage>987</fpage>‐<lpage>997</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijrobp.2020.10.024</pub-id>
<pub-id pub-id-type="pmid">33127493</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0048">
                <label>48</label>
                <mixed-citation publication-type="journal" id="cncr34377-cit-0048"><string-name><surname>Swaroop</surname><given-names>MN</given-names></string-name>, <string-name><surname>Ferguson</surname><given-names>CM</given-names></string-name>, <string-name><surname>Horick</surname><given-names>NK</given-names></string-name>, et al. <article-title>Impact of adjuvant taxane‐based chemotherapy on development of breast cancer‐related lymphedema: results from a large prospective cohort</article-title>. <source>Breast Cancer Res Treat</source>. <year>2015</year>;<volume>151</volume>(<issue>2</issue>):<fpage>393</fpage>‐<lpage>403</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10549-015-3408-1</pub-id>
<pub-id pub-id-type="pmid">25940996</pub-id></mixed-citation>
              </ref>
              <ref id="cncr34377-bib-0049">
                <label>49</label>
                <mixed-citation publication-type="miscellaneous" id="cncr34377-cit-0049"><collab collab-type="authors">National Comprehensive Cancer Network</collab>
. Accessed November 1, <year>2021</year>. <ext-link xlink:href="https://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf" ext-link-type="uri">https://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdf</ext-link>
</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
